EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma. [electronic resource]
- Cancer letters 09 2016
- 191-200 p. digital
Publication Type: Journal Article
1872-7980
10.1016/j.canlet.2016.05.032 doi
AMP-Activated Protein Kinases--metabolism Animals Apoptosis--radiation effects Carcinoma--enzymology Cell Line, Tumor DNA Breaks, Double-Stranded DNA Repair DNA-Activated Protein Kinase--metabolism Dose-Response Relationship, Radiation Enzyme Activation Epstein-Barr Virus Infections--virology Female Glycolysis Herpesvirus 4, Human--metabolism Host-Pathogen Interactions Humans Mice, Inbred BALB C Mice, Nude Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms--enzymology Nuclear Proteins--metabolism Phosphorylation Radiation Tolerance Signal Transduction--radiation effects Time Factors Tumor Burden--radiation effects Viral Matrix Proteins--metabolism Xenograft Model Antitumor Assays